Revenues increased 28% year-over-year to EUR 13.4 million for the first six months
104% growth in its HIFU business outside of USA for the first six months
Solid financial profile with cash position of $17.5 million
Strong backlog of orders in both HIFU and ESWL entering Third Quarter
LYON, France, Aug.
Monsanto Company (NYSE: MON) today announced fiscal year 2014 results
slightly above the high end of its guidance range on the strength of its
global seeds and traits business, the biggest driver of growth for the
Allied World Assurance Company Holdings, AG (NYSE:AWH) today reported
net income of $30.9 million, or $0.31 per diluted
share, for the third quarter of 2014 compared to net income of $122.8
million, or $1.18 per diluted share, for the third quarter of 2013.
Revenues increased 27% year-over-year to EUR 20.3 million (USD 27.4 million) for the first nine months of 2014
HIFU revenue increased 114% year-over-year during first nine months of 2014
Positive operating income, excluding FDA-related costs, for three and nine months ended September 30, 2014
Solid financial profile with cash position of EUR 11.1 million (USD 14.0 million)
Three Focal One Systems sold during third quarter, demonstrates robust OUS demand for next-generation HIFU device
Recent FDA guidance on Ablatherm HIFU PMA submission provides clear U.S. regulatory path and opportunity.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.